Yes - this was covered last webinar I believe. The delay has impacted the forecasts to a tune of 1m. Infusions were on track to meet their guidance anyway so the delay has had an impact but they still are very likely to beat 21m.
I am thinking a bit more conservative in a 21.5-22.5m estimate for the full year but I hope there is slightly more upside.
Provided the targets are largely met and well explained I will be happy. I am interested in the next forecast because WP has been in the job long enough to make more accurate forecasts. Keep in mind the 21m figure was in the middle of a major restructure so hitting it will be a big achievement in my books!
Questions for Webinar, page-48
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.92 |
Change
-0.300(2.45%) |
Mkt cap ! $258.3M | |||
| Open | High | Low | Value | Volume |
| $12.20 | $12.22 | $11.60 | $65.72K | 5.534K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 257 | $11.63 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.92 | 294 | 1 |
View Market Depth
| Last trade - 10.33am 21/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |